We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Two Transplant Patients Develop Melanoma from Donor

By HospiMedica staff writers
Posted on 03 Mar 2003
Two Scottish patients who received a kidney transplant developed melanoma from their kidneys, in spite of the fact that the donor was treated for melanoma 16 years earlier and considered to be free of cancer. More...
The two cases were reported in the February 6, 2003, issue of The New England Journal of Medicine (NEJM).

According to a doctor involved in the transplant, the melanoma cells had been dormant in the kidneys of the donor but flourished when the patients were given medications to suppress their immune systems in order to prevent rejection. One of the patients found to have melanoma died about a year and a half later. The second patient, whose cancer was confined to the kidney, is on dialysis following removal of the transplanted kidney and is now doing well. Previously, the longest interval known between a transplant and donor-caused melanoma was eight years.

The researchers, writing in the New England Journal of Medicine, suggest that nobody who has had melanoma should ever be an organ donor. The US transplant network strongly discourages the use of organs from donors who have a history of melanoma or other cancers. In any case, the primary doctor of an organ donor should be asked about the donor's medical history.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.